ABU DHABI / GULF TIME In a groundbreaking moment for luxury real estate, the German ...
Read More »Seha, Sanofi ink agreement to advance rare disease diagnostics
ABU DHABI / WAM The Abu Dhabi Health Services Company (Seha), a subsidiary of PureHealth, and Sanofi, have entered into a collaboration agreement, to enhance diagnostic performance and accuracy in the field of rare diseases. The agreement will particularly focus on expediting the screening process for lysosomal storage disorders (LSDs) and reducing the average diagnostic journey for rare disease patients. ...
Read More »